NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sim&Cure

Sim&Cure

Private
MontpellierHealthcare & Life Scienceshttps://sim-and-cure.com/

Last Round

Series A

Extension

Nov 28, 2024

Total Funding Raised

$16.62M

Company Overview

Sim&Cure is a healthtech company that develops AI-driven digital twin software solutions to assist clinicians in the planning and personalization of endovascular treatments for cerebral aneurysms.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Medical Devices, 3D Printing

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital twinsoftware as a medical deviceSaMDcerebral aneurysmneurovascular interventionclinical decision supportsurgical planningmedical imagingsurgical simulationmedical AI3D printingmedtechsurgical trainingvirtual surgeryAI in healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sim&Cure Comparables

Compare Sim&Cure with similar companies based on industry and business-model similarity.

Sim&Cure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ArteryFlow Technology
89%
Materialise
79%
Mentice AB
77%

Sim&Cure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionNov 28, 2024
Series AApr 23, 2019
SeedJun 21, 2016

Key People

Founding team and executive leadership

Mathieu Sanchez

CEO, co-founder

Founding Team

Dan Raffi

Chief Operating Officer

Executive Team

Sim&Cure Investors

Notable investors and investment history

Sim&Cure investors
InvestorRounds
SofilaroSeries A Extension
Elaia PartnersSeries A, Series A Extension
TudigoSeries A Extension
HolnestSeries A Extension
SWEN Capital PartnersSeries A Extension
IT-TranslationSeed, Series A
IRDI Soridec GestionSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 3550% MoM, from 10 to 365.

  • Nov 28, 2024

    $11M round led by Elaia Partners.

Sim&Cure Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sim&Cure Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sim&Cure's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontpellier
Employee Range65
Year Founded2014
Last FundingNov 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.